Rehashing endocannabinoid antagonists: can we selectively target the periphery to safely treat obesity and type 2 diabetes? (full – 2010)http://www.jci.org/articles/view/44099?search[abstract_text]=&search[article_text]=cannabinoid&search[authors_text]=&search[fpage]=&search[title_text]=&search[volume]=
A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2990160/
The novel cannabinoid CB1 antagonist AM6545 suppresses food intake and food-reinforced behavior (full – 2010)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3522179/
Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity (full – 2010)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2912197/
Peripherally restricted CB1 receptor blockers (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23902803
2012 Division of Medicinal Chemistry Award Address: Trekking the Cannabinoid Road: A Personal Perspective (full– 2014)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064474/
A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2990160/
The novel cannabinoid CB1 antagonist AM6545 suppresses food intake and food-reinforced behavior (full – 2010)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3522179/
Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity (full – 2010)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2912197/
Peripherally restricted CB1 receptor blockers (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23902803
2012 Division of Medicinal Chemistry Award Address: Trekking the Cannabinoid Road: A Personal Perspective (full– 2014)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064474/